FIRAZYR sol inj 30 mg/3ml ser pré 3 ml
7680581780015
CH-58178
B06AC02
02.99.0.
Reimbursement limitations:
FIRAZYR2
Traitement symptomatique des crises aiguës d’angio-œdème héréditaire (AOH) chez les adultes, les adolescents et les …
1 / 2
google
Details
- Product number
- 5817801
- CPT
- -
- Packaging group
- 1 x 3
- Unit
- ml
- Composition
- icatibantum 10 mg ut icatibanti acetas, natrii chloridum, acidum aceticum glaciale, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.35 mg.
Articles (1)
Firazyr 30 mg/3 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1 x 3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.35 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1951.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2010
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 58178
- Drug name
- Firazyr, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- B06AC02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/06/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 02.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FIRAZYR sol inj 30 mg/3ml ser pré 3 ml
- Description (DE)
- FIRAZYR Inj Lös 30 mg/3ml Fertspr 3 ml
- Market launch
- 17/06/2009
- Narcotic (BTM)
- No